U.S. Markets closed

Mallinckrodt Public Limited Company (MNK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
36.39+0.03 (+0.08%)
At close: 4:01PM EDT
People also watch
TELPNRHZNPENDPPRGO
Full screen
Previous Close36.36
Open36.06
Bid0.00 x 0
Ask0.00 x 0
Day's Range35.87 - 36.75
52 Week Range35.04 - 85.83
Volume1,503,492
Avg. Volume2,640,262
Market Cap3.62B
Beta1.62
PE Ratio (TTM)-11.38
EPS (TTM)-3.2
Earnings DateJan 31, 2017 - Feb 6, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est66.64
Trade prices are not sourced from all markets
  • Mallinckrodt Plc – Value Analysis (NYSE:MNK) : August 17, 2017
    Capital Cube2 days ago

    Mallinckrodt Plc – Value Analysis (NYSE:MNK) : August 17, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Mallinckrodt Plc a score of 50. Our analysis is based on comparing Mallinckrodt Plc with the following peers – Johnson & Johnson, Mylan N.V., Zogenix, Inc., Depomed, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR and General Electric Company (JNJ-US, MYL-US, ZGNX-US, DEPO-US, TEVA-US and GE-US). Investment Outlook ... Read more (Read more...)

  • Zacks4 days ago

    Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak

    Mallinckrodt undertaking strategic acquisitions and divestitures to evolve as a high-performing specialty pharmaceutical company.

  • PR Newswire4 days ago

    Mallinckrodt To Present At Morgan Stanley 15th Annual Global Healthcare Conference

    STAINES-UPON-THAMES, United Kingdom , Aug. 15, 2017 /PRNewswire/ --  Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, Sept. 12, 2017 ...